Cancer Supportive Care Products Market - Growth rate And Revenue Forecast 2018-2026 | Amgen Inc. ,Johnson & Johnson & Fagron Group BV
According to the World Cancer Research Fund International (WCRF), there would be more than 24 million cancer cases worldwide by 2035, with non-melanoma skin cancer not included in the estimates. According to the National Cancer Institute (NIH), more than a million and a half new cases of cancer were diagnosed in the United States in 2017. Because of the high and rising prevalence of cancer, several healthcare organizations have thrown their hats in the ring, and the demand for cancer-related products is skyrocketing.
According to In this business intelligence report, demand for the cancer supportive care products market will grow at a CAGR of 4.8 percent from 2017 to 2021.
According to
the report's researchers, the global opportunities in the cancer supportive
care products market will generate revenue of US$ 31,700.0 Mn by the end of
2021, which is much higher than the industry's anticipated worth of US$
26,285.5 Mn in 2017.
Aside from
the growing prevalence of cancer, which has drawn the attention of several
organizations and governments, the worldwide cancer supportive care products the market is influenced by several other factors. Increasing global elderly
population, improved anti-cancer treatment effectiveness, higher spending power
of urban populations in emerging economies, and product innovation is only a
few of them.
Biosimilar
entry, the higher high cost of research and development processes, and
regulatory restrictions, on the other hand, are some of the restraints
preventing the industry from thriving. Nonetheless, vendors in the cancer
supportive care products market are projected to benefit from new prospects in
Asia Pacific's densely populated rising economies and by boosting their R&D
spending.
Geographically,
the demand for cancer supportive care products in the global market is
dominated by North America. By the end of 2021, the North American region, led
by the industrialized country of the United States, is expected to account for
44.2 percent of global demand, followed by the densely populated Asia Pacific the region at 24.7 percent.
While North
America has a strong healthcare infrastructure and a high rate of new
technology adoption, Asia Pacific is home to two of the most promising growing
economies – China and India – where urban population discretionary income is
fast expanding.
- Amgen Inc. is a biotech company based in California.
- Johnson & Johnson is a pharmaceutical company.
- Novartis AG is a pharmaceutical company based in Switzerland.
- Baxter International Inc. is a pharmaceutical company based in the United States.
- Fagron Group BV is a company based in the Netherlands.
- Teva Pharmaceutical Industries Ltd. is a pharmaceutical company based in Israel.

Comments
Post a Comment